This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2 - 4 November 2021
Delivered in GMT time zone



Meet Clinscience. A globally operating, market-leading CRO offering an expansive portfolio of services covering your every clinical trial operational need.

With a key focus on creating a healthier future and supporting the launch of new products that improve patients' expectancy and quality of life, we are driven by data and technology, are ISO certified, FDA and EMA compliant, and exceptionally experienced with all well-known clinical trial systems (CTMS, eTMF, eCRF).

Operating across 25 countries including North America and Europe, we excel in multiple key areas including Clinical Development and Operations, Biostatistics and Data Management, Pharmacovigilance, Regulatory, Quality Services, and Phase I-IV Clinical Trials on both new drugs and medical devices. Our exemplary record of success speaks for itself with over 72k patients participating in more than 440 of our completed clinical projects; it’s unquestionable to see that the scale, professionalism, and quality of our services are unrivaled.

Furthermore, we are proud to have direct access to 63 clinical research sites, including hospitals, via our International Research Site Network, and boast an operational network of specialists and key influencers spanning multiple continents who are on-hand to assist your project and drive success. When combined with our strategic CRO partnerships spanning Asia and Mid-East, we are truly your Global project enabler.

Our clients range from pharmaceutical and biotechnology companies, through scientific and research institutions to start-ups in the industry, and our innovative approach to business, coupled with localized knowledge, understanding, and care allows us to deliver meaningful value throughout every engagement. Simply put, we go beyond meeting study requirements to help drive the strategy, trial execution, investigational product and device positioning directly into medical practice.

Via the unique boutique structure we offer to our partners we have a dynamic agility which allows us to undertake projects regardless of their current status, including the provision of a range of valuable services for clients with clinical programs at an early stage of development such as R&D Program Design and Study Strategizing, Medical Consultancy, Writing & Monitoring, and Study Feasibility. While our organizational network and publicly traded parent company Neuca (WSE:NEU - €2bn revenue FY19) provides stability, backend services, and strength to meet your needs and exceed your expectations.

European Headquartered with a worldwide reach, we have access to a readily available, diverse portfolio of 300 million prospective patients for Clinical Trials from a wide socioeconomic spectrum with the EU; offering an array of benefits including a lower rate of studies per populous, higher compliance and strict data protection. We have over 50 ongoing projects in operation currently and boast outstanding client satisfaction and retention rates across every aspect of our business.

By displaying clear, ethical values throughout every part of our operations, including the underlying fundamental goal that every patient should have access to the best clinical therapies, we value ideas over hierarchy and nurture technology as a core competency to enable us to remain at the forefront of delivering precision throughout our services, and excellence to our valued clients.